Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Hamostaseologie|August 14, 2021
Diagnosing Inherited Platelet Disorders: Modalities and ConsequencesCarlo Zaninetti, Martina Wolff, Andreas GreinacherJournal of Thrombosis and Haemostasis : JTH|April 3, 2020
Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodiesMartina Wolff, Stefan Handtke, Raghavendra Palankar, et al.Journal of Thrombosis and Haemostasis : JTH|March 18, 2022
α-hemolysin of Staphylococcus aureus impairs thrombus formationKristin Jahn, Stefan Handtke, Raghavendra Palankar, et al.Journal of Thrombosis and Haemostasis : JTH|August 25, 2022
Quantitative interpretation of PF4/heparin-EIA optical densities in predicting platelet-activating VITT antibodiesLinda Schönborn, Thomas Thiele, Max Esefeld, et al.Blood|May 4, 2021
A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccinationStefan Handtke, Martina Wolff, Carlo Zaninetti, et al.Thrombosis and Haemostasis|December 17, 2021
Polyvalent Immunoglobulin Preparations Inhibit Pneumolysin-Induced Platelet DestructionFriederike Wiebe, Stefan Handtke, Jan Wesche, et al.Blood Advances|December 22, 2020
Pneumolysin induces platelet destruction, not platelet activation, which can be prevented by immunoglobulin preparations in vitroKristin Jahn, Stefan Handtke, Raghavendra Palankar, et al.Journal of Thrombosis and Haemostasis : JTH|December 16, 2023
Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopeniaCarlo Zaninetti, Jose' Rivera, Leonard Vater, et al.Blood|September 29, 2021
Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopeniaAndreas Greinacher, Kathleen Selleng, Raghavendra Palankar, et al.Pageof 1